Cyclosporine/Loteprednol Etabonate

环孢素/氯替泼诺

Report date: 2026/03/09 20:02:04

Base Information

Drug NameCyclosporine/Loteprednol Etabonate
Drug Alias NameN/A
ClassificationSmall molecules > Steroids
Mechanisms of ActionCalcineurin inhibitorsMitocliondrial permeability transition pore inhibitorsCytosolic phospholipase A2 agonists +[6] 
TargetsCalcineurinMitocliondrial permeability transition poreGlucocorticoid receptor +[5] 
Therapy Area/IndicationsXerophthalmia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsYes CyclosporineLoteprednol Etabonate
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesResearch Insight Llc
China Registration ClassN/A

Develop Information

Active CompaniesResearch Insight Llc
Inactive CompaniesN/A
Active IndicationsXerophthalmia
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A